Drug Information and Literature Evaluation

Drug Information and Literature Evaluation
ISBN-10
0857110667
ISBN-13
9780857110664
Category
Clinical trials
Pages
225
Language
English
Published
2013
Publisher
Pharmaceutical Press
Authors
Marie A. Abate, Matthew L. Blommel

Description

This book teaches students how to effectively and efficiently locate and analyze up-to-date drug information and literature. It succinctly examines key drug information and literature-evaluation principles - the proper approach for answering drug health information questions, tertiary and secondary resources, and practice guideline, systematic reviews and meta-analyses. Every chapter includes self-assessment questions; answers are located at the back of the book.

Similar books

  • Clinical Trials: Design, Conduct, and Analysis
    By Curtis L. Meinert, Susan Tonascia

    Mather HG , Pearson NG , Read KLQ , Steed GR , Thorne MG , Jones S , Guerrier CJ , Eraut 2 CD , McHugh PM , Chowdhury NR , Jafary MH , Wallace TJ : Acute myocardial infarction : Home and hospital treatment .

  • Clinical Trials in Neurology: Design, Conduct, Analysis
    By Bernard Ravina

    Comprehensive book that suggests ways to improve the efficiency of clinical trials and the development of interventions in the neurosciences.

  • 50 Studies Every Pediatrician Should Know
    By Michael Levy, Nina L. Shapiro, Stephen C. Aronoff

    50 Studies Every Pediatrician Should Know presents summaries of key studies that have shaped the current clinical practice of pediatrics. Numerous subspecialties are covered, including cardiology and neonatology.

  • Good Clinical Practice: A Question & Answer Rference Guide, May 2014
    By Michael R. Hamrell

    The completely updated and expanded 2013 guide includes: Input from an Expert Advisory Panel including distinguished international GCP experts who have assured that the book contains the most current and up-to-date information on global GCP ...

  • Self-Controlled Case Series Studies
    By Paddy Farrington, Heather Whitaker, Yonas Ghebremichael Weldeselassie

    The method only requires information from individuals who have experienced the event of interest, and automatically controls for multiplicative time-invariant confounders, even when these are unmeasured or unknown.

  • Fundamentals of Clinical Trials
    By Lawrence M. Friedman, David L. DeMets, Curt Furberg

    Brownlee KA : Statistical theory and methodology in science and engineering , New York , 1965 , John Wiley & Sons . 21. ... DeSilva RA , Hennekcns CH , Lown B , Casscells W : Lignocaine prophylaxis in acute myocardial infarction : an ...

  • America's Top Doctors for Cancer

    Name Gradishar , William J ( IL ) Grado , Gordon L ( AZ ) Graham , Mark ( NC ) Graham , Michael L ( AZ ) Graham - Pole ... Clarence S ( CA ) Greenson , Joel K ( MI ) Greenway , Hubert T ( CA ) Greer , Benjamin ( WA ) Greer , John P ...

  • Critical Appraisal of Epidemiological Studies and Clinical Trials
    By Mark Elwood

    J. Mark Elwood. Q6.10 A screening test applied to 1000 subjects identified 100 of them as positive. ... Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for noncardia ...

  • Reviewing Clinical Trials: A Guide for the Ethics Committee
    By Washington, Inc, Chinese University of Hong Kong

    The idea for this manual came from Pfizer in the US, which provided the Clinical Trials Centre at The University of Hong Kong, Hong Kong SAR, PR China with a nonbinding grant for its development.

  • SARS: Clinical Trials on Treatment Using a Combination of Traditional Chinese Medicine and Western Medicine

    SARS is a newly identified human infection caused by a corona virus unlike any other known human or animal virus in its family.